Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2024-8781
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
Container Escape Vulnerability in TR7's Application Security Platform (ASP)
Source: NVD (National Vulnerability Database)
Vulnerability Description
Execution with Unnecessary Privileges, : Improper Protection of Alternate Path vulnerability in TR7 Application Security Platform (ASP) allows Privilege Escalation, -Privilege Abuse.This issue affects Application Security Platform (ASP): v1.4.25.188.
Source: NVD (National Vulnerability Database)
CVSS Information
N/A
Source: NVD (National Vulnerability Database)
Vulnerability Type
带着不必要的权限执行
Source: NVD (National Vulnerability Database)
Vulnerability Title
TR7 Application Security Platform 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
TR7 Application Security Platform是TR7公司的一款应用程序。 TR7 Application Security Platform 1.4.25.188版本存在安全漏洞,该漏洞源于对备用路径漏洞的不当保护,从而允许权限提升和权限滥用。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
TR7Application Security Platform (ASP) v1.4.25.188 -
II. Public POCs for CVE-2024-8781
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2024-8781
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2024-8781

No comments yet


Leave a comment